Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | DV281 |
| Trade Name | |
| Synonyms | DV-281|DV 281 |
| Drug Descriptions |
DV281 is a TLR9 agonist, which may stimulate cytotoxic T-lymphocytes to enhance the immune anti-tumor response (PMID: 30502651). |
| DrugClasses | TLR9 Agonist 9 |
| CAS Registry Number | NA |
| NCIT ID | C143006 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| DV281 | DV281 | 0 | 1 |
| DV281 + Nivolumab | DV281 Nivolumab | 0 | 0 |